About MAA Laboratories Inc.

MAA Laboratories Inc. is a specialty pharmaceutical company located in the Research Triangle Park region of North Carolina. MAA has developed the NanoCont^TM drug development platform as a broadly applicable solution for addressing a variety of drug delivery and solubility challenges. The company is dedicated to using the NanoCont^TM technology to create advanced medicines that address unmet clinical needs for patients and provide intellectual property protection to our pharmaceutical partners.

The NanoCont^TM drug development platform

MAA Laboratories’ NanoCont^TM technology is a broadly applicable drug development solution for improving the clinical performance of poorly soluble pharmaceuticals. Aspects of drug performance that can be improved by the NanonCont^TM technology include: increased therapeutic efficiency, enhanced targeted drug delivery, elimination of food effects, increased oral bioavailability, reduced intra- and inter-patient variability, and/or mitigated undesirable side effects. This technology can be used to reformulate marketed products in a manner that resolves known drug performance liabilities and creates new intellectual property protection. For investigational compounds, the NanoCont^TM technology can be used to overcome hurdles related to low solubility and poor bioavailability to ensure consistent dosing and facilitating the development of promising pipeline compounds.